Tissue transglutaminase: A mediator and predictor of chronic allograft nephropathy?

Transplantation

Volumn 77, Issue 11, 2004, Pages 1667-1675

  Johnson, Timothy S ^a,c   Abo Zenah, Hamdy ^a   Skill, James N ^a,b   Bex, Samantha ^c   Wild, Graham ^c   Brown, Colin B ^a   Griffin, Martin ^b   El Nahas, Meguid ^a  

^a Sheffield Kidney Institute   (United Kingdom)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 (GAMMA GLUTAMYL)LYSINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE TRANSGLUTAMINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DISEASE MARKER; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MEDIATOR; MESANGIUM CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN TARGETING;

ADULT; CHRONIC DISEASE; DIPEPTIDES; EXTRACELLULAR FLUID; FEMALE; GTP-BINDING PROTEINS; HUMANS; IMMUNOLOGIC TECHNIQUES; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; SOLUBILITY; STAINING AND LABELING; TISSUE DISTRIBUTION; TRANSGLUTAMINASES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 2942631084     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000131171.67671.3C     Document Type: Article

References (30)

1. Gjerston D. Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry. In: Terasaki PI, Cacka A, eds. Clinical transplantation. Los Angeles, UCLA Tissue Typing Laboratory 1992, p. 299.
2. Tullis S, Tilney N. Both alloantigen-dependent and independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
3. Hayry P, Isoneime H, Yilmaz S, et al. Chronic allograft rejection. Immunology 1993; 134: 33.
4. Tilney N, Paul L. Alloantigen-dependent events leading to chronic graft dysfunction. In: Tilney NL, Strom TB, Paul LC, eds. Transplantation biology: Cellular and molecular aspects. Philadelphia. New York, Lippincott-Raven 1996, p. 567.
5. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56: 783.
6. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
7. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banffworking classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
8. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290.
9. Skill NJ, Griffin M, El Nahas AM, et al. Increases in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: pathologic implications. Lab Invest 2001; 81: 705.
10. Johnson TS, Skill NJ, El Nahas AM, et al. Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol 1999; 10: 2146.
11. Folk JE, Finlayson JS. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 1977; 31: 1.
12. Aeschlimann D, Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 2000; 41: 1.
13. Johnson TS, Knight CR, el-Alaoui S, et al. Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene 1994; 9: 2935.
14. Fesus L, Madi A, Balajthy Z, et al. Transglutaminase induction by various cell death and apoptosis pathways. Experientia 1996; 52: 942.
15. Nunes I, Gleizes PE, Metz CN, et al. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 1997; 136: 1151.
16. Kleman JP, Aeschlimann D, Paulsson M, et al. Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 1995; 34: 13768.
17. Small K, Feng JF, Lorenz J, et al. Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J Biol Chem 1999; 274: 21291.
18. Mirza A, Liu SL, Frizell E, et al. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol 1997; 272: G281.
19. Griffin M, Smith LL, Wynne J. Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol 1979; 60: 653.
20. Nicholson ML, Harper SJ, Wheatley TJ, et al. Renal transplant fibrosis: histomorphometric assessment of early renal transplant biopsies for markers of chronic rejection. Transplant Proc 1997; 29: 2793.
21. Abo-Zenah H, Katsoudas S, de Takats D, et al. Early progressive interstitial fibrosis in human renal allografts. Clin Nephrol 2002; 57: 9.
22. Johnson TS, El-Koraie AF, Skill NJ, et al. Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol 2003; 14: 2052.
23. Akimov SS, Belkin AM. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001; 98: 1567.
24. Verderio E, Nicholas B, Gross S, et al. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res 1998; 239: 119.
25. Cheigh JS, Mouradian J, Soliman M, et al. Focal segmental glomerulosclerosis in renal transplants. Am J Kidney Dis 1983; 2: 449.
26. Goumenos DS, Brown CB, Shortland J, et al. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 1994; 9: 1418.
27. Akimov S, Belkin AM. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGF beta-dependent matrix deposition. J Cell Sci 2001; 114: 2989.
28. Border WA, Noble NA. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 1997; 51: 1388.
29. Johnson TS, Griffin M, Thomas GL, et al. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 1997; 99: 2950.
30. Johnson TS, Scholfield CI, Parry J, et al. Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas. Biochem J 1998; 331: 105.